Rapid Therapeutic Science Laboratories, Inc. (RTSL)
0.002
0.00 (0.00%)
USD |
OTCM |
Jan 21, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.038M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -47.37% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 100.00% |
Profile
| Rapid Therapeutic Science Laboratories, Inc. operates as an early stage emerging biotech company in the legal hemp and cannabis space. The company develops a new method of formulation and manufacturing to deliver pure CBD, THC, and combinations in legal jurisdictions to consumers. It holds a sublicense agreement to access certain technology regarding the Rxoid metered dose inhaler, which is a medical technology that delivers medication directly to a user's blood stream through the pulmonary tract. It serves customers in the state of Texas. The company was founded on February 22, 2013 and is headquartered in De Leon, TX. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | Texas |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Rapid Therapeutic Science Laboratories, Inc. operates as an early stage emerging biotech company in the legal hemp and cannabis space. The company develops a new method of formulation and manufacturing to deliver pure CBD, THC, and combinations in legal jurisdictions to consumers. It holds a sublicense agreement to access certain technology regarding the Rxoid metered dose inhaler, which is a medical technology that delivers medication directly to a user's blood stream through the pulmonary tract. It serves customers in the state of Texas. The company was founded on February 22, 2013 and is headquartered in De Leon, TX. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | Texas |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |